Cassava Sciences Inc (SAVA)
28.48
-3.38
(-10.62%)
USD |
NASDAQ |
Sep 27, 16:00
28.47
-0.02
(-0.05%)
After-Hours: 20:00
Cassava Sciences Net Income (Annual): -97.22M for Dec. 31, 2023
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -97.22M |
| December 31, 2022 | -76.25M |
| December 31, 2021 | -32.38M |
| December 31, 2020 | -6.334M |
| December 31, 2019 | -4.631M |
| December 31, 2018 | -6.557M |
| December 31, 2017 | -11.91M |
| December 31, 2016 | -14.85M |
| December 31, 2015 | -14.14M |
| December 31, 2014 | -12.39M |
| December 31, 2013 | 31.54M |
| December 31, 2012 | -3.446M |
| December 31, 2011 | -2.613M |
| Date | Value |
|---|---|
| December 31, 2010 | -12.02M |
| December 31, 2009 | -3.467M |
| December 31, 2008 | 15.35M |
| December 31, 2007 | 20.30M |
| December 31, 2006 | 6.188M |
| December 31, 2005 | -30.67M |
| December 31, 2004 | -37.78M |
| December 31, 2003 | -21.62M |
| December 31, 2002 | -15.92M |
| December 31, 2001 | -14.34M |
| December 31, 2000 | -17.48M |
| December 31, 1999 | -4.500M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-97.22M
Minimum
2023
-4.631M
Maximum
2019
-43.36M
Average
-32.38M
Median
2021
Net Income (Annual) Benchmarks
| Bristol-Myers Squibb Co | 8.025B |
| Eli Lilly and Co | 5.240B |
| Seelos Therapeutics Inc | -37.88M |
| Moderna Inc | -4.714B |
| Biomarin Pharmaceutical Inc | 167.64M |